Malignant Supratentorial Neoplasm

1 clinical trials · Condition

Record	Firm	Date
Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide (NCT00102648)	M.D. Anderson Cancer Center	2004-12-21

Every clearance here is in the API, with alerts when new ones post.